Timaeus use in phase IV studies

Do your future prescribers enjoy their experience of conducting your clinical trial?

Phase IV and post-marketing studies are important in gaining further data and information on the risks, benefits and optimal use of marketed medicines. In particular, they often attempt to simulate the real world more than perhaps very rigidly controlled Phase II and Phase III studies. Phase IV trials are therefore not usually conducted in specialist clinical trials centres, but instead in the physicians' offices and at the clinics and hospitals where the majority of patients are routinely seen.

Therefore it is vital that the needs of Investigator sites participating in Phase IV studies are fully recognised. Successful collaboration, patient enrolment and establishment of a good rapport with Phase IV sites is doubly important for pharmaceutical and biotechnology companies. These physicians are typically their customers when it comes to prescribing the approved medicines.

During the development of Timaeus, one strong advocate and sponsor was the Global Phase IV Medical Affairs department of a major pharmaceutical company. They recognized the value of establishing good relationships with their Phase IV sites and saw Timaeus as being an ideal tool to help them. They provided sponsorship for surveys and workshops of Investigators to help guide Timaeus to become their "magic box" — a real aid in conducting a clinical trial. They even coined their own name for Timaeus — ISuit, which stood for "Investigator Site Suitable".

They recognised the competitive nature of Phase IV studies and the positive impact of well-conducted studies. They wanted to be the sponsor of choice for Investigators. For more information on why Timaeus is so well suited to support Phase IV studies, please read about the Investigator site research that was conducted and the resulting design features of Timaeus in Investigator site wishes.